US 10,213,392 · Application 15/648,314 · Granted Feb 26, 2019
US 10,213,392
Pharmaceutical composition for use in medical and veterinary ophthalmology
Estimated expiration
June 10, 2029
2y 254d remaining
- Could not fetch continuity data for application PCTRU2009000295: Resource not found (404)
Earliest effective filing
Jun 10, 2009
+ 20 years
Jun 10, 2029
PTA +0d
Jun 10, 2029
No TD
—
Final
Jun 10, 2029
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- July 12, 2017
- Earliest effective filing
- June 10, 2009
- Issue date
- February 26, 2019
- PTA
- 0 days
- Base expiry (before PTA)
- June 10, 2029
June 10, 2009 + 20 years = June 10, 2029
- Divisional of application 13/315,397, filed Dec 9, 2011, issued as US 9,724,313
- Continuation-in-part of application PCTRU2009000295, filed Jun 10, 2009
- Continuation-in-part of application PCTRU2009000295, filed Jun 10, 2009
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 15/648,314 · US 10,213,392
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 10,213,392: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US10213392Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.